Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02066129 · ClinicalTrials.gov registry record · Phase 3
Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations
A Phase 3 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 254
- Enrollment target
NCT02066129 is a Phase 3 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 254 participants.
The verdict
NCT02066129, a Phase 3 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 254 participants
- Enrollment target
Study Summary
The objective of this study is to determine whether, in children receiving low-dose inhaled corticosteroids (ICS), quintupling the dose of inhaled corticosteroids at the onset of symptoms previously associated with upper respiratory illnesses and subsequent asthma exacerbations reduces the rate of severe asthma exacerbations treated with oral corticosteroids.
Interventions
- DRUG Fluticasone 44 mcg
- DRUG Fluticasone 220 mcg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2014-07 |
| Est. Completion | 2017-04-21 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02066129
The ClinicalTrials.gov registry entry for NCT02066129 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 254 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fluticasone 44 mcg is the first listed.
NCT02066129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02066129 about?
NCT02066129 is a clinical study titled "Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations". The objective of this study is to determine whether, in children receiving low-dose inhaled corticosteroids (ICS), quintupling the dose of inhaled corticosteroids at the onset of symptoms previously associated with upper respiratory illnesses and subsequent asthma exacerbations reduces the rate of s...
What is the current status of trial NCT02066129?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 254 participants. The study started on 2014-07. Estimated completion is 2017-04-21.
What interventions are being tested in trial NCT02066129?
The interventions under investigation include: Fluticasone 44 mcg (DRUG), Fluticasone 220 mcg (DRUG).
Who is sponsoring clinical trial NCT02066129?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.